Lusis et al. (26) assessed 49 meningiomas (20 grade I and 29 grades II and III), identifying NDRG2 expression in 79% of grade I meningiomas and 23% of grades II and III meningiomas. This evidence concerns the gene NDRG2 and meningioma.